Akebia Therapeutics (AKBA) EBT Margin Growth (3y) (2020 - 2026)
Akebia Therapeutics (AKBA) EBT Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1,282.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 58.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -861.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -1,020.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -995.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 1,157.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Akebia Therapeutics | 244.72 Mn | 89.17 Mn | 38.70 Mn | 183.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 183.00 |
| Mar 31, 2026 | 5,051.00 |
| Dec 31, 2025 | -1,210.00 |
| Sep 30, 2025 | 10,975.00 |
| Jun 30, 2025 | -2,443.00 |
| Mar 31, 2025 | 8.20 Mn |
| Dec 31, 2024 | -9,385.00 |
| Sep 30, 2024 | 6,457.00 |
| Jun 30, 2024 | 13,539.00 |
| Mar 31, 2024 | 7,416.00 |
| Dec 31, 2023 | 40,111.00 |
| Sep 30, 2023 | 36,527.00 |
| Jun 30, 2023 | 17,515.00 |
| Mar 31, 2023 | 148.00 |
| Dec 31, 2022 | 32,543.00 |
| Sep 30, 2022 | 45,084.00 |
| Jun 30, 2022 | 22,771.00 |
| Mar 31, 2022 | -8.18 Mn |
| Dec 31, 2021 | 21,150.00 |
| Sep 30, 2021 | -6,912.00 |